NDC 72241-003

Nateglinide

Nateglinide

Nateglinide is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Modavar Pharmaceuticals Llc. The primary component is Nateglinide.

Product ID72241-003_af81465b-5f49-4eeb-8122-ef7fe5d90ddc
NDC72241-003
Product TypeHuman Prescription Drug
Proprietary NameNateglinide
Generic NameNateglinide
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2021-08-19
Marketing CategoryANDA /
Application NumberANDA206432
Labeler NameModavar Pharmaceuticals LLC
Substance NameNATEGLINIDE
Active Ingredient Strength120 mg/1
Pharm ClassesGlinide [EPC], Potassium Channel Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 72241-003-04

90 TABLET, COATED in 1 BOTTLE (72241-003-04)
Marketing Start Date2021-08-19
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Nateglinide" or generic name "Nateglinide"

NDCBrand NameGeneric Name
0591-3354NateglinideNateglinide
0591-3355NateglinideNateglinide
0615-7585NateglinideNateglinide
0615-7586NateglinideNateglinide
16571-758NATEGLINIDENATEGLINIDE
16571-759NATEGLINIDENATEGLINIDE
42291-636NateglinideNateglinide
42291-637NateglinideNateglinide
49884-984NateglinideNateglinide
49884-985NateglinideNateglinide
51407-656Nateglinidenateglinide
51407-657Nateglinidenateglinide
52536-063NateglinideNateglinide
52536-067NateglinideNateglinide
55111-328NateglinideNateglinide
55111-329NateglinideNateglinide
60429-434NateglinideNateglinide
60429-435NateglinideNateglinide
60687-673Nateglinidenateglinide
60687-684Nateglinidenateglinide
64380-167Nateglinidenateglinide
64380-168Nateglinidenateglinide
68084-458NateglinideNateglinide
68084-459NateglinideNateglinide
68382-721NateglinideNateglinide
68382-722NateglinideNateglinide
70771-1016NateglinideNateglinide
70771-1015NateglinideNateglinide
71209-030NateglinideNateglinide
71209-031NateglinideNateglinide
75834-205NATEGLINIDENATEGLINIDE
75834-206NATEGLINIDENATEGLINIDE
0078-0351Starlixnateglinide
0078-0352Starlixnateglinide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.